Josh Riggs - Apr 11, 2024 Form 4 Insider Report for Oncocyte Corp (OCX)

Role
CEO and President, Director
Signature
/s/ Josh Riggs
Stock symbol
OCX
Transactions as of
Apr 11, 2024
Transactions value $
$10,001
Form type
4
Date filed
4/15/2024, 06:04 AM
Previous filing
Aug 17, 2023
Next filing
May 22, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction OCX Common Stock, no par value Purchase $10K +3.39K +2947.83% $2.95 3.51K Apr 11, 2024 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Reflects shares of the Issuer's common stock, no par value, purchased by the Reporting Person from the Issuer in a private offering.